LNLiang Niu

Liang Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liang Niu has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Race and Regional Differences in Cerebral Microbleeds in Individuals with Incident Stroke or Transient Ischemic Attack: The REGARDS Study

    by Oluchi Ekenze, Liang Niu, Russell P. Sawyer, Aleena Bennet, Mary Cushman, Vasileios-Arsenios Lioutas, Hugo J. Aparicio, Sudha Seshadri, Virginia J. Howard, Jose R. Romero, et al.

    Background: Cerebral microbleeds (CMBs) are associated with risk of stroke, cognitive impairment, and dementia. The influence of race and/or region of residence on CMB is underexplored. Methods: REasons for Geographic and Racial Differences in Stroke (REGARDS) study participants with incident stroke/TIA and available MRI were included. CMBs were classified as any, non-lobar, lobar or mixed CMB. Counts were recorded. Multivariable logistic regression assessed associations between race and/or region of residence with CMB presence. Multivariable negative binomial regression related these factors to CMB counts. Models adjusted for age, sex, vascular risk factors. Results: Among 808 participants (317 Black participants, 412 in stroke belt), Black participants had higher odds of any CMB, odds ratio (OR) = 1.72; 95% confidence interval (CI) 1.22, 2.43). Stroke belt residents had lower odds of any (OR = 0.51, 95% CI 0.37, 0.72), non-lobar (OR = 0.46; 95% CI 0.24, 0.85), lobar (OR = 0.60; 95% CI 0.38, 0.93) CMBs and lower odds of CMB counts (rate ratio [RR] = 0.66, 95% CI 0.43, 0.99). Black participants residing in the stroke belt had higher odds of any (OR = 1.88; 95% CI 1.11, 3.20) and mixed (OR = 2.99; 95% CI 1.19, 7.74) CMBs. Conclusions: Black participants had higher risk for CMBs. Higher risk in Black participants may suggest increased subclinical vascular brain injury.

  • Efficient gene set analysis for DNA methylation addressing probe dependency and bias

    by Zongli Xu, Alison A Motsinger-Reif, Liang Niu

    Motivation: Gene Set Enrichment Analysis (GSEA) is widely used to interpret DNA methylation data by associating differentially methylated sites with biological pathways. However, existing GSEA methods struggle with several challenges in methylation data, including probe dependency, probe number bias, and the complexity of gene-probe mapping. These limitations can lead to biased enrichment results, reduced statistical power, and computational inefficiencies. Results: We introduce gsGene and gsPG, two novel GSEA methods specifically designed for DNA methylation data. gsGene aggregates association signals at gene level while correcting for probe dependency and probe number bias, enabling more biologically meaningful enrichment analysis. gsPG takes a different approach by conducting gene set enrichment using summary statistics for independent probe groups based on gene annotation, mitigating biases from multi-mapping probes. Both methods improve computational efficiency, enhance statistical power, and effectively control type I error rates. Comprehensive evaluations in two large datasets demonstrate superior performance compared to existing methods. Furthermore, we propose a novel beta distribution fitting strategy to improve enrichment P-value estimation, providing a computationally efficient alternative to traditional permutation-based gene set methods. Availability and implementation: These methods are implemented in the R package dmGsea, which is freely available on GitHub and Bioconductor (DOI: 10.18129/B9.bioc.dmGsea). The package supports Illumina 450K, EPIC, and mouse methylation arrays and can be extended to other omics data with user-provided probe-to-gene mapping annotations.


  • Open Access

    methscore: a comprehensive R function for DNA methylation-based health predictors

    by Zongli Xu, Liang Niu, Jacob K Kresovich, Jack A Taylor

    Motivation: DNA methylation-based predictors of various biological metrics have been widely published and are becoming valuable tools in epidemiologic studies of epigenetics and personalized medicine. However, generating these predictors from original source software and web servers is complex and time consuming. Furthermore, different predictors were often derived based on data from different types of arrays, where array differences and batch effects can make predictors difficult to compare across studies. Results: We integrate these published methods into a single R function to produce 158 previously published predictors for chronological age, biological age, exposures, lifestyle traits and serum protein levels using both classical and principal component-based methods. To mitigate batch and array differences, we also provide a modified RCP method (ref-RCP) that normalize input DNA methylation data to reference data prior to estimation. Evaluations in real datasets show that this approach improves estimate precision and comparability across studies. Availability and implementation: The function was included in software package ENmix, and is freely available from Bioconductor website (https://www.bioconductor.org/packages/release/bioc/html/ENmix.html).


  • Open Access

    Endemic Coronavirus Infections are Associated with Strong Homotypic Immunity in a US Cohort of Children from Birth to 4 Years

    by Ardythe L Morrow, Daniel C Payne, Shannon C Conrey, Meredith McMorrow, Monica M McNeal, Liang Niu, Allison R Burrell, Elizabeth P Schlaudecker, Claire Mattison, Rachel M Burke, et al.

    Background: The endemic coronaviruses OC43, HKU1, NL63, and 229E cause cold-like symptoms and are related to SARS-CoV-2, but their natural histories are poorly understood. In a cohort of children followed from birth to 4 years, we documented all coronavirus infections, including SARS-CoV-2, to understand protection against subsequent infections with the same virus (homotypic immunity) or a different coronavirus (heterotypic immunity). Methods: Mother–child pairs were enrolled in metropolitan Cincinnati during the third trimester of pregnancy in 2017-2018. Mothers reported their child’s sociodemographics, risk factors, and weekly symptoms. Mid-turbinate nasal swabs were collected weekly. Blood was collected at 6 weeks, 6, 12, 18, 24 months, and annually thereafter. Infections were detected by testing nasal swabs by an RT-PCR multi-pathogen panel and by serum IgG responses. Health care visits were documented from pediatric records. Analysis was limited to 116 children with high sample adherence. Reconsent for monitoring SARS-CoV-2 infections from June 2020 through November 2021 was obtained for 74 (64%) children. Results: We detected 345 endemic coronavirus infections (1.1 infections/child-year) and 21 SARS-CoV-2 infections (0.3 infections/child-year). Endemic coronavirus and SARS-CoV-2 infections were asymptomatic or mild. Significant protective homotypic immunity occurred after a single infection with OC43 (77%) and HKU1 (84%) and after two infections with NL63 (73%). No heterotypic protection against endemic coronaviruses or SARS-CoV-2 was identified. Conclusions: Natural coronavirus infections were common and resulted in strong homotypic immunity but not heterotypic immunity against other coronaviruses, including SARS-CoV-2. Endemic coronavirus and SARS-CoV-2 infections in this US cohort were typically asymptomatic or mild.


  • Stable methylation loci are associated with systolic blood pressure in a Croatian island population

    by Alexander C Sprague, Liang Niu, Roman Jandarov, Xiang Zhang, Ge Zhang, Aimin Chen, Jelena Šarac, Miran Čoklo, Sasa Missoni, Pavao Rudan, et al.

    Background: The objective was to identify stable and dynamic DNA methylation loci associated with cardiometabolic traits among an adult population from the Croatian island of Hvar. Materials & meth... Plain language summary Cardiovascular disease is the leading cause of death worldwide. Previous studies have found that genetics incompletely explain susceptibility to cardiovascular disease. To fi... Tweetable abstract New research from @UC_CoMResearch describes an epigenome-wide association study that suggests an association between stable methylation at multiple loci and adult systolic blood ... Graphical abstract


  • Open Access

    Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis in US Mothers and Children Aged 0-2: PREVAIL Cohort Study

    by Ardythe L Morrow, Mary A Staat, Emily A DeFranco, Monica M McNeal, Allison R Cline, Shannon C Conrey, Elizabeth P Schlaudecker, Alexandra M Piasecki, Rachel M Burke, Liang Niu, et al.

    Background: Acute gastroenteritis (AGE) and acute respiratory infections (ARIs) cause significant pediatric morbidity and mortality. Developing childhood vaccines against major enteric and respiratory pathogens should be guided by the natural history of infection and acquired immunity. The United States currently lacks contemporary birth cohort data to guide vaccine development. Objective: The PREVAIL (Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal) Cohort study was undertaken to define the natural history of infection and immune response to major pathogens causing AGE and ARI in US children. Methods: Mothers in Cincinnati, Ohio, were enrolled in their third trimester of pregnancy, with intensive child follow-up to 2 years. Blood samples were obtained from children at birth (cord), 6 weeks, and 6, 12, 18, and 24 months. Whole stool specimens and midturbinate nasal swabs were collected weekly and tested by multipathogen molecular assays. Saliva, meconium, maternal blood, and milk samples were also collected. AGE (≥3 loose or watery stools or ≥1 vomiting episode within 24 hours) and ARI (cough or fever) cases were documented by weekly cell phone surveys to mothers via automated SMS text messaging and review of medical records. Immunization records were obtained from registries and providers. follow-up ended in October 2020. Pathogen-specific infections are defined by a PCR-positive sample or rise in serum antibody. Results: Of the 245 enrolled mother–child pairs, 51.8% (n=127) were White, 43.3% (n=106) Black, 55.9% (n=137) publicly insured, and 86.5% (n=212) initiated breastfeeding. Blood collection was 100.0% for mothers (n=245) and 85.7% for umbilical cord (n=210). A total of 194/245 (79.2%) mother–child pairs were compliant based on participation in at least 70% (≥71/102 study weeks) of child-weeks and providing 70% or more of weekly samples during that time, or blood samples at 18 or 24 months. Compliant participants (n=194) had 71.0% median nasal swab collection (IQR 30.0%-90.5%), with 98.5% (191/194) providing either an 18- or 24-month blood sample; median response to weekly SMS text message surveys was 95.1% (IQR 76.5%-100%). Compliant mothers reported 2.0 AGE and 4.5 ARI cases per child-year, of which 25.5% (160/627) and 38.06% (486/1277) of cases, respectively, were medically attended; 0.5% of AGE (3/627) and 0.55% of ARI (7/1277) cases were hospitalized. Conclusions: The PREVAIL Cohort demonstrates intensive follow-up to document the natural history of enteric and respiratory infections and immunity in children 0-2 years of age in the United States and will contribute unique data to guide vaccine recommendations. Testing for pathogens and antibodies is ongoing. International Registered Report Identifier (IRRID): RR1-10.2196/22222


  • Open Access

    ipDMR: identification of differentially methylated regions with interval P-values

    by Zongli Xu, Changchun Xie, Jack A Taylor, Liang Niu

    IpDMR is an R software tool for identification of differentially methylated regions (DMRs) using auto-correlated P-values for individual CpGs from epigenome-wide association analysis using array or bisulfite sequencing data. It summarizes P-values for adjacent CpGs, identifies association peaks and then extends peaks to find boundaries of DMRs. ipDMR uses BED format files as input and is easy to use. Simulations guided by real data found that ipDMR outperformed current available methods and provided slightly higher true positive rates and much lower false discovery rates. ipDMR is available at https://bioconductor.org/packages/release/bioc/html/ENmix.html. Supplementary data are available at Bioinformatics online.


  • Open Access

    Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis in US Mothers and Children Aged 0-2: PREVAIL Cohort Study (Preprint)

    by Ardythe L Morrow, Mary A Staat, Emily A DeFranco, Monica M McNeal, Allison R Cline, Shannon C Conrey, Elizabeth P Schlaudecker, Alexandra M Piasecki, Rachel M Burke, Liang Niu, et al.

    BACKGROUND Acute gastroenteritis (AGE) and acute respiratory infections (ARIs) cause significant pediatric morbidity and mortality. Developing childhood vaccines against major enteric and respiratory pathogens should be guided by the natural history of infection and acquired immunity. The United States currently lacks contemporary birth cohort data to guide vaccine development. OBJECTIVE The PREVAIL (Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal) Cohort study was undertaken to define the natural history of infection and immune response to major pathogens causing AGE and ARI in US children. METHODS Mothers in Cincinnati, Ohio, were enrolled in their third trimester of pregnancy, with intensive child follow-up to 2 years. Blood samples were obtained from children at birth (cord), 6 weeks, and 6, 12, 18, and 24 months. Whole stool specimens and midturbinate nasal swabs were collected weekly and tested by multipathogen molecular assays. Saliva, meconium, maternal blood, and milk samples were also collected. AGE (≥3 loose or watery stools or ≥1 vomiting episode within 24 hours) and ARI (cough or fever) cases were documented by weekly cell phone surveys to mothers via automated SMS text messaging and review of medical records. Immunization records were obtained from registries and providers. follow-up ended in October 2020. Pathogen-specific infections are defined by a PCR-positive sample or rise in serum antibody. RESULTS Of the 245 enrolled mother–child pairs, 51.8% (n=127) were White, 43.3% (n=106) Black, 55.9% (n=137) publicly insured, and 86.5% (n=212) initiated breastfeeding. Blood collection was 100.0% for mothers (n=245) and 85.7% for umbilical cord (n=210). A total of 194/245 (79.2%) mother–child pairs were compliant based on participation in at least 70% (≥71/102 study weeks) of child-weeks and providing 70% or more of weekly samples during that time, or blood samples at 18 or 24 months. Compliant participants (n=194) had 71.0% median nasal swab collection (IQR 30.0%-90.5%), with 98.5% (191/194) providing either an 18- or 24-month blood sample; median response to weekly SMS text message surveys was 95.1% (IQR 76.5%-100%). Compliant mothers reported 2.0 AGE and 4.5 ARI cases per child-year, of which 25.5% (160/627) and 38.06% (486/1277) of cases, respectively, were medically attended; 0.5% of AGE (3/627) and 0.55% of ARI (7/1277) cases were hospitalized. CONCLUSIONS The PREVAIL Cohort demonstrates intensive follow-up to document the natural history of enteric and respiratory infections and immunity in children 0-2 years of age in the United States and will contribute unique data to guide vaccine recommendations. Testing for pathogens and antibodies is ongoing. INTERNATIONAL REGISTERED REPORT RR1-10.2196/22222

  • Open Access

    ChIAPoP: a new tool for ChIA-PET data analysis

    by Weichun Huang, Mario Medvedovic, Jingwen Zhang, Liang Niu

    Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET) is a popular assay method for studying genome-wide chromatin interactions mediated by a protein of interest. The main goal of ChIA-PET data analysis is to detect interactions between DNA regions. Here, we propose a new method and the associated data analysis pipeline, ChIAPoP, to detect chromatin interactions from ChIA-PET data. We compared ChIAPoP with other popular methods, including a hypergeometric model (used in ChIA-PET tool), MICC (used in ChIA-PET2), ChiaSig and mango. The results showed that ChIA-PoP performed better than or at least as well as these top existing methods in detecting true chromatin interactions. ChIAPoP is freely available to the public at https://github.com/wh90999/ChIAPoP.


  • Open Access

    The BRUCE‐ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development

    by Chunmin Ge, Chrystelle L. Vilfranc, Lixiao Che, Raj K. Pandita, Shashank Hambarde, Paul R. Andreassen, Liang Niu, Olugbenga Olowokure, Shimul Shah, Susan E. Waltz, et al.

    Replication fork stability during DNA replication is vital for maintenance of genomic stability and suppression of cancer development in mammals. ATR (ataxia‐telangiectasia mutated [ATM] and RAD3‐related) is a master regulatory kinase that activates the replication stress response to overcome replication barriers. Although many downstream effectors of ATR have been established, the upstream regulators of ATR and the effect of such regulation on liver cancer remain unclear. The ubiquitin conjugase BRUCE (BIR Repeat containing Ubiquitin‐Conjugating Enzyme) is a guardian of chromosome integrity and activator of ATM signaling, which promotes DNA double‐strand break repair through homologous recombination. Here we demonstrate the functions for BRUCE in ATR activation in vitro and liver tumor suppression in vivo. BRUCE is recruited to induced DNA damage sites. Depletion of BRUCE inhibited multiple ATR‐dependent signaling events during replication stress, including activation of ATR itself, phosphorylation of its downstream targets CHK1 and RPA, and the mono‐ubiquitination of FANCD2. Consequently, BRUCE deficiency resulted in stalled DNA replication forks and increased firing of new replication origins. The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin diethylnitrosamine. Liver‐specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human hepatocellular carcinoma (HCC). In humans, the clinical relevance of BRUCE down‐regulation in liver disease was found in hepatitis, cirrhosis, and HCC specimens, and deleterious somatic mutations of the Bruce gene was found in human hepatocellular carcinoma in the Cancer Genome Atlas database. Conclusion: These findings establish a BRUCE‐ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.